Literature DB >> 9921315

Experimental infection of swine by Isospora suis Biester 1934 for species confirmation.

S M Sayd1, U Kawazoe.   

Abstract

A survey of Isospora suis performed in 177 faecal samples from 30 swine farms detected thin wall type I. suis oocysts in seven samples. This type of oocyst measuring 23.9 by 20.7 microns had a retracted thin wall similar to that of the genus Sarcocystis. This type of oocysts, isolated from four different faecal samples, was inoculated in four-five-days-old piglets free of contamination in order to verify the life cycle and pathogenicity of the species. The pigs were kept in individual metal cages and fed with cow milk. Daily faecal collections and examinations were performed until the 21st day after infection. MacMaster and Sheather's methods were used for oocyst counting and identification. Infected piglets produced yellowish-pasty diarrhoea with slight dehydration. The prepatent and patent periods were respectively from 6 to 9 and 3 to 10 days after infection. Oocyst elimination was interrupted on the 10th and 11th days after infection with biphasic cycles. Thin and thick wall oocysts were detected in the same faecal samples. Thin walls were not observed in unsporulated oocytes. The observations suggest that this type of oocysts could appear in specific strains which occur in the later stages of their development. These oocysts seem to be responsible for clinical and pathogenic signs of neonatal isosporosis in pigs.

Entities:  

Mesh:

Year:  1998        PMID: 9921315     DOI: 10.1590/s0074-02761998000600028

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  1 in total

1.  Bumped kinase inhibitor 1369 is effective against Cystoisospora suis in vivo and in vitro.

Authors:  Aruna Shrestha; Kayode K Ojo; Florian Koston; Bärbel Ruttkowski; Rama S R Vidadala; Carlie S Dorr; Edelmar D Navaluna; Grant R Whitman; Kayleigh F Barrett; Lynn K Barrett; Matthew A Hulverson; Ryan Choi; Samantha A Michaels; Dustin J Maly; Andrew Hemphill; Wesley C Van Voorhis; Anja Joachim
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-04-02       Impact factor: 4.077

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.